Director, Alternative Fee Intelligence and Analytics, GlaxoSmithKline
Justin Ergler is the Director of Alternative Fee Intelligence and Analytics for GlaxoSmithKline based in Research Triangle Park, NC. In his current role, he is responsible for the compilation and analysis of alternative fee arrangement intelligence, the development of predictive cost modeling tools for new engagements, and accelerating the transition to non-hourly, value-based fee arrangements at GSK and in the Legal industry at large. Justin started his career with GlaxoSmithKline in 2005 as part of the award winning Prospects In Procurement program, where he worked at developing sourcing strategies across numerous business units at GSK. Justin began working with the GSK Legal department in 2008 as a Sourcing Group Manager for Legal Services Procurement. In that role, Justin received numerous awards for his part in the development and execution of GSK’s Outside Counsel Selection Initiative (OCSI) for all new significant matters and across all practice areas at GSK. Justin holds a Business degree from the University of North Carolina at Chapel Hill and is a veteran of the United States Army's 3rd Infantry Division.